Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis (Q36836702)

16 August 2017

1 reference

21 April 2021

1 reference

PubMed publication ID

18599555

title

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis. (English)

1 reference

hormone replacement therapy

16 August 2017

cerebrovascular disease

1 reference

17 November 2019

1 reference

17 June 2019

venous thromboembolism

1 reference

21 April 2021

1 reference

13 November 2019

1 reference

17 November 2019

2 references

PubMed publication ID

21 April 2021

Hormone Replacement Therapy

1 reference

1 reference

Laura J Gray

2

0 references

Philip M W Bath

object named as

Philip M W Bath

series ordinal

3

0 references

author name string

Gillian M Sare

series ordinal

1

1 reference

16 August 2017

language of work or name

1 reference

3 July 2008

1 reference

16 August 2017

1 August 2008

10 references

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

19 June 2019

25 June 2019

13 November 2019

17 November 2019

21 April 2021

European Heart Journal

11 references

16 August 2017

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

19 June 2019

25 June 2019

13 November 2019

17 November 2019

21 April 2021

29

1 reference

16 August 2017

16

1 reference

16 August 2017

2031-2041

1 reference

Creative Commons Attribution-NonCommercial

16 August 2017

10 references

14 March 2019

19 March 2019

22 March 2019

25 April 2019

17 June 2019

19 June 2019

25 June 2019

13 November 2019

17 November 2019

21 April 2021

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Progesterone for the treatment of experimental brain injury; a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

HRT and the primary prevention of cardiovascular disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Mechanisms of neuroprotection by estrogen

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Estrogens and experimental ischemic stroke: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Hormone replacement therapy and acute myocardial infarction: a large observational study exploring the influence of age.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Treatment of menopausal symptoms: what shall we do now?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Association between hormone replacement therapy and subsequent stroke: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Hormone therapy and venous thromboembolism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Evidence from randomised trials on the long-term effects of hormone replacement therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Quantifying heterogeneity in a meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Clinical cardiovascular studies of hormone replacement therapy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Effects of hormone replacement therapy on cognitive aging and dementia risk in postmenopausal women: a review of ongoing large-scale, long-term clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Bias in meta-analysis detected by a simple, graphical test

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Cardiovascular disease in women: implications of hormone replacement therapy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Composite and surrogate outcomes in randomised controlled trials.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Use of ordinal outcomes in vascular prevention trials: comparison with binary outcomes in published trials

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Measuring quality of life in a way that is meaningful to stroke patients.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Megatrials of hormonal replacement therapy.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2515884

Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease

5 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHN299

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

21 January 2018

1 reference

12 December 2020

Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm

1 reference

12 December 2020

The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results

1 reference

12 December 2020

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

12 December 2020

Identifiers

DOI

10.1093/EURHEARTJ/EHN299

1 reference

release_zrc3bktlffh4lhiohvqto2jqdu

16 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zrc3bktlffh4lhiohvqto2jqdu

24 November 2022

mapped directly with Wikidata item

1 reference

16 August 2017

PubMed publication ID

18599555

1 reference